Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 9,250.00
-140.00 (-1.49%)
At close: Oct 29, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 142.14 billion as of October 29, 2026. It is the 24,589th most valuable company in the world and the 1,023rd biggest in South Korea. Its market cap has decreased by 51.95% in one year.
Market Cap
142.14B
Enterprise Value
120.12B
Revenue
3.17B
Global Rank
Country Rank
#1,023 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 5, 2023, Y-Biologics's market cap has decreased from 177.50B to 142.14B, a decrease of -19.92%. That is a compound annual growth rate of -7.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 142.14B | -59.11% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 190.37B |
| Kangstem Biotech | 178.61B |
| curacle co.,ltd. | 177.70B |
| NIBEC | 161.20B |
| ISU Abxis | 142.30B |
| Bio Solution | 140.89B |
| Kanaph Therapeutics | 128.35B |
| Ensol Biosciences | 128.24B |